6.06
Capricor Therapeutics Inc 주식(CAPR)의 최신 뉴스
Capricor Therapeutics, Inc. Long-Term Shareholder - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Capricor Therapeutics, Inc. (CAPR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Capricor Therapeutics (CAPR) Projected to Post Quarterly Earnings on Monday - MarketBeat
What insider purchases suggest about Capricor Therapeutics Inc. (4LN2) stockQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com
What valuation multiples suggest for Capricor Therapeutics Inc. stockRecession Risk & Target Return Focused Picks - newser.com
How high can Capricor Therapeutics Inc. stock go2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Why Capricor Therapeutics Inc. stock is a must watch in 2025July 2025 Patterns & Fast Entry High Yield Tips - newser.com
Will Capricor Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Activity Recap & Community Verified Watchlist Alerts - newser.com
Chart based analysis of Capricor Therapeutics Inc. trends2025 Technical Overview & Technical Pattern Based Signals - newser.com
What hedge fund moves indicate for Capricor Therapeutics Inc. (4LN2) stock2025 Year in Review & Proven Capital Preservation Tips - newser.com
Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback - Stocktwits
Will Capricor Therapeutics Inc. (4LN2) stock announce a stock splitJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
Can Capricor Therapeutics Inc. stock hit analyst price targets2025 Market Overview & Weekly High Return Opportunities - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock see insider accumulationWeekly Stock Summary & Verified Momentum Stock Alerts - newser.com
Capricor Therapeutics (CAPR) Advances DMD Treatment with New Res - GuruFocus
Strategies to average down on Capricor Therapeutics Inc.2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel - The Manila Times
Capricor Therapeutics Publishes Peer-Reviewed Study in - GlobeNewswire
Smart tools for monitoring Capricor Therapeutics Inc.’s price actionJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock a momentum leader2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Will Capricor Therapeutics Inc. price bounce be sustainableQuarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock outperform energy sector in 2025July 2025 Earnings & Trade Opportunity Analysis - newser.com
Price momentum metrics for Capricor Therapeutics Inc. explained2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
What institutional flow reveals about Capricor Therapeutics Inc.July 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Capricor Therapeutics Inc.’s volatility index tracking explainedGap Up & Daily Growth Stock Tips - newser.com
Chart overlay techniques for tracking Capricor Therapeutics Inc.Weekly Trend Summary & Community Supported Trade Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is it too late to sell Capricor Therapeutics Inc.Market Movers & Community Driven Trade Alerts - newser.com
HBK Sorce Advisory LLC Increases Stake in Capricor Therapeutics, Inc. $CAPR - MarketBeat
Capricor Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 - The Manila Times
Capricor Therapeutics to Announce Third Quarter 2025 Financial Results on November 10, 2025 - Quiver Quantitative
Capricor (NASDAQ: CAPR) schedules financial results call for Nov 10 at 4:30 p.m. ET - Stock Titan
자본화:
|
볼륨(24시간):